ClinConnect ClinConnect Logo
Search / Trial NCT05622682

Vaccine Immune Recovery After Leukemia

Launched by CHILDREN'S HOSPITAL OF PHILADELPHIA · Nov 9, 2022

Trial Information

Current as of August 21, 2025

Enrolling by invitation

Keywords

Acute Lymphoblastic Leukemia Chemotherapy Antineoplastic Agents Varicella Vaccine Chickenpox Vaccine Pneumococcal Vaccines Measles Vaccine

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Children, adolescents, and young adults diagnosed with B or T ALL at age 12 months or older
  • Completed ALL chemotherapy within the past three months or will complete ALL chemotherapy in the upcoming three months
  • Three years of age or older at time of enrollment
  • Exclusion Criteria:
  • Diagnosis of infant ALL
  • Evidence of disease relapse
  • History of primary immunodeficiency (except related to Down Syndrome)
  • History of a stem cell transplant or cellular immunotherapy
  • History of prior malignancy or condition requiring chemotherapy other than for current ALL diagnosis

About Children's Hospital Of Philadelphia

The Children's Hospital of Philadelphia (CHOP) is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and clinical care. As a prominent clinical trial sponsor, CHOP emphasizes a multidisciplinary approach to pediatric research, fostering collaborations across various specialties to develop and evaluate groundbreaking therapies and interventions. With a focus on improving patient outcomes and enhancing the quality of life for children, CHOP is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards and scientific integrity, ultimately contributing to the global knowledge base in pediatric medicine.

Locations

Philadelphia, Pennsylvania, United States

Seattle, Washington, United States

Chicago, Illinois, United States

Grand Rapids, Michigan, United States

Nashville, Tennessee, United States

San Antonio, Texas, United States

Patients applied

0 patients applied

Trial Officials

Brian T Fisher, DO MSCE MPH

Principal Investigator

Children's Hospital of Philadelphia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials